相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HIF-1 alpha suppressing small molecule, LW6, inhibits cancer cell growth by binding to calcineurin b homologous protein 1
Beom Seok Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Design, synthesis, and structure-activity relationships of 1-ethylpyrazole-3-carboxamide compounds as novel hypoxia-inducible factor (HIF)-1 inhibitors
Yorinobu Yasuda et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: Synthesis, anti-invasive and anti-angiogenic properties
Lihui Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
New Inhibitors of Angiogenesis with Antitumor Activity in Vivo
Nagore I. Marin-Ramos et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients
Anatole Besarab et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
The role of hypoxia-inducible factor-2 in digestive system cancers
J. Zhao et al.
CELL DEATH & DISEASE (2015)
HIF-1α pathway: role, regulation and intervention for cancer therapy
Georgina N. Masoud et al.
ACTA PHARMACEUTICA SINICA B (2015)
Diacylglycerol Kinase (DGK) Inhibitor II (R59949) Could Suppress Retinal Neovascularization and Protect Retinal Astrocytes in an Oxygen-Induced Retinopathy Model
Lu Yang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2015)
Development of a Novel Class of Mitochondrial Ubiquinol-Cytochrome c Reductase Binding Protein (UQCRB) Modulators as Promising Antiangiogenic Leads
Hye Jin Jung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Fructose-1,6-bisphosphatase opposes renal carcinoma progression
Bo Li et al.
NATURE (2014)
A Synthetic Manassantin A Derivative Inhibits Hypoxia-Inducible Factor 1 and Tumor Growth
Liwei Lang et al.
PLOS ONE (2014)
In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics
Brooke Bullock Lao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Identification of Malate Dehydrogenase 2 as a Target Protein of the HIF-1 Inhibitor LW6 using Chemical Probes
Kyeong Lee et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance
A. P. Toner et al.
BRITISH JOURNAL OF CANCER (2013)
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Gregg L. Semenza
JOURNAL OF CLINICAL INVESTIGATION (2013)
Hypoxia-Inducible Factor and Vascular Endothelial Growth Factor Pathway for the Study of Hypoxia in a New Model of Otitis Media with Effusion
Qiuhong Huang et al.
AUDIOLOGY AND NEURO-OTOLOGY (2012)
The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function
L. C. J. Baker et al.
BRITISH JOURNAL OF CANCER (2012)
Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP
Shaoman Yin et al.
CLINICAL CANCER RESEARCH (2012)
Targeting the von Hippel-Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction
Dennis L. Buckley et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology
Wei Wang et al.
PLOS ONE (2012)
Passing the baton: the HIF switch
Mei Yee Koh et al.
TRENDS IN BIOCHEMICAL SCIENCES (2012)
SR16388: a steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivo
Wan-Ru Chao et al.
ANGIOGENESIS (2011)
Manassantin A Isolated from Saururus chinensis Inhibits 5-Lipoxygenase-Dependent Leukotriene C4 Generation by Blocking Mitogen-Activated Protein Kinase Activation in Mast Cells
Su Jeong Kim et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Identification of a novel small molecule targeting UQCRB of mitochondrial complex III and its anti-angiogenic activity
Hye Jin Jung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
Yin Wang et al.
CELL STEM CELL (2011)
HIF-VEGF Pathways Are Critical for Chronic Otitis Media in Junbo and Jeff Mouse Mutants
Michael T. Cheeseman et al.
PLOS GENETICS (2011)
LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1α via upregulation of VHL in a colon cancer cell line
Kyeong Lee et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Pleiotropic Effects of YC-1 Selectively Inhibit Pathological Retinal Neovascularization and Promote Physiological Revascularization in a Mouse Model of Oxygen-Induced Retinopathy
M. DeNiro et al.
MOLECULAR PHARMACOLOGY (2010)
Analysis of HIF-1 inhibition by manassantin A and analogues with modified tetrahydrofuran configurations
Amanda C. Kasper et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Inhibition of Phenotypic and Functional Maturation of Dendritic Cells by Manassantin A
Jee Youn Kim et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2009)
Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1
Dong Hoon Shin et al.
BLOOD (2008)
ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo
Christian Moser et al.
BMC CANCER (2008)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1α
Shan Hua Li et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198
Theresa M. LaVallee et al.
MOLECULAR CANCER THERAPEUTICS (2008)
(Aryloxyacetylamino)benzoic acid analogues: A new class of hypoxia-inducible factor-1 inhibitors
Kyeong Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
RACK1 competes with HSP90 for binding to HIF-1α and is required for O2-independent and HSP90 inhibitor-induced degradation of HIF-1α
Ye V. Liu et al.
MOLECULAR CELL (2007)
A mutation in the F-box gene, Fbxo11, causes otitis media in the Jeff mouse
Rachel E. Hardisty-Hughes et al.
HUMAN MOLECULAR GENETICS (2006)
Mutation at the Evi1 locus in Junbo mice causes susceptibility to otitis media
Nicholas Parkinson et al.
PLOS GENETICS (2006)
Development of novel therapeutic strategies that target HIF-1
GL Semenza
EXPERT OPINION ON THERAPEUTIC TARGETS (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
DH Kong et al.
CANCER RESEARCH (2005)
Saururus cernuus lignans -: Potent small molecule inhibitors of hypoxia-inducible factor-1
CF Hossain et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Activation of HIF-prolyl hydroxylases by R59949, an inhibitor of the diacylglycerol kinase
E Temes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Terpenoid tetrahydroisoquinoline alkaloids emetine, klugine, and isocephaeline inhibit the activation of hypoxia-inducible factor-1 in breast tumor cells
YD Zhou et al.
JOURNAL OF NATURAL PRODUCTS (2005)
Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1α induction in response to hypoxic stress and growth factors
NM Chau et al.
CANCER RESEARCH (2005)
Molecular-targeted antitumor agents:: The Saururus cernuus dineolignans manassantin B and 4-O-demethylmanassantin B are potent inhibitors of hypoxia-activated HIF-1
TW Hodges et al.
JOURNAL OF NATURAL PRODUCTS (2004)
Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: An orally bioavailable heat shock protein 90 modulator
G Kaur et al.
CLINICAL CANCER RESEARCH (2004)
Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway
AL Kung et al.
CANCER CELL (2004)
Tumor hypoxia: Causative factors, compensatory mechanisms, and cellular response
P Vaupel et al.
ONCOLOGIST (2004)
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules
BJ Moeller et al.
CANCER CELL (2004)
Lignans from Saururus chinensis inhibiting the transcription factor NF-κB
BY Hwang et al.
PHYTOCHEMISTRY (2003)
Regulation of nitric oxide-sensitive guanylyl cyclase
A Friebe et al.
CIRCULATION RESEARCH (2003)
Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival
J Raffel et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2003)
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
NJ Mabjeesh et al.
CANCER CELL (2003)
Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway
JS Isaacs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family
KS Hewitson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
HIF-1 and tumor progression: pathophysiology and therapeutics
GL Semenza
TRENDS IN MOLECULAR MEDICINE (2002)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells
YS Chun et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
M Ohh et al.
NATURE CELL BIOLOGY (2000)
The aetiology of otitis media with effusion: a review
H Kubba et al.
CLINICAL OTOLARYNGOLOGY (2000)
分享论文
